Cargando…
Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: A multicenter study
INTRODUCTION: Post-hepatectomy liver failure (PHLF) is one of the most serious complications and causes of death in patients with hepatocellular carcinoma (HCC) after hepatectomy. This study aimed to develop a novel machine learning (ML) model based on the light gradient boosting machines (LightGBM)...
Autores principales: | Wang, Jitao, Zheng, Tianlei, Liao, Yong, Geng, Shi, Li, Jinlong, Zhang, Zhanguo, Shang, Dong, Liu, Chengyu, Yu, Peng, Huang, Yifei, Liu, Chuan, Liu, Yanna, Liu, Shanghao, Wang, Mingguang, Liu, Dengxiang, Miao, Hongrui, Li, Shuang, Zhang, Biao, Huang, Anliang, Zhang, Yewei, Qi, Xiaolong, Chen, Shubo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667038/ https://www.ncbi.nlm.nih.gov/pubmed/36408144 http://dx.doi.org/10.3389/fonc.2022.986867 |
Ejemplares similares
-
Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study
por: Wang, Jitao, et al.
Publicado: (2023) -
Noninvasively Assessed Portal Hypertension Grade Predicts Post-Hepatectomy Liver Failure in Patients With HepatocellCarcinoma: A Multicenter Study
por: Wang, Jitao, et al.
Publicado: (2022) -
A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
por: Wang, Jitao, et al.
Publicado: (2022) -
Prediction of Survival and Analysis of Prognostic Factors for Patients With Combined Hepatocellular Carcinoma and Cholangiocarcinoma: A Population-Based Study
por: Wang, Jitao, et al.
Publicado: (2021) -
Inversed albumin-to-globulin ratio and underlying liver disease severity as a prognostic factor for survival in hepatocellular carcinoma patients undergoing transarterial chemoembolization
por: Li, Jinlong, et al.
Publicado: (2023)